Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    18281656 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: celecoxib;   Drug: gemcitabine hydrochloride;   Drug: zileuton
2 Completed
Has Results
0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer
Conditions: Lung Cancer;   Non Small Cell Lung Cancer
Interventions: Drug: apricoxib;   Drug: Placebo;   Drug: Docetaxel or Pemetrexed

Study has passed its completion date and status has not been verified in more than two years.